When and how should magnetic resonance imaging be used in evaluation of the patient with prostate cancer or increased prostate specific antigen?

Affiliations

Editorial

Arnauld Villers et al. J Urol. 2013 Nov.

. 2013 Nov;190(5):1641-2.

doi: 10.1016/j.juro.2013.08.014. Epub 2013 Aug 15.

¹ Department of Urology, Hospital Huriez, University Lille Nord de France, Lille, France.

No abstract available

Comment on

The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.
Somford DM, Hamoen EH, Fütterer JJ, van Basten JP, Hulsbergen-van de Kaa CA, Vreuls W, van Oort IM, Vergunst H, Kiemeney LA, Barentsz JO, Witjes JA. Somford DM, et al. J Urol. 2013 Nov;190(5):1728-34. doi: 10.1016/j.juro.2013.05.021. Epub 2013 May 13. J Urol. 2013. PMID: 23680307
Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer.
Rais-Bahrami S, Siddiqui MM, Turkbey B, Stamatakis L, Logan J, Hoang AN, Walton-Diaz A, Vourganti S, Truong H, Kruecker J, Merino MJ, Wood BJ, Choyke PL, Pinto PA. Rais-Bahrami S, et al. J Urol. 2013 Nov;190(5):1721-1727. doi: 10.1016/j.juro.2013.05.052. Epub 2013 May 29. J Urol. 2013. PMID: 23727310 Free PMC article.